Department of Neurosurgery, University of Marburg, Marburg, Germany.
Neuro Oncol. 2011 Dec;13(12):1339-48. doi: 10.1093/neuonc/nor133. Epub 2011 Sep 12.
Extent of resection (EOR) still remains controversial in therapy of glioblastoma multiforme (GBM). However, an increasing number of studies favor maximum EOR as being associated with longer patient survival. One hundred thirty-five GBM patients underwent tumor resection aided by 1.5T intraoperative MRI (iMRI) and integrated multimodal navigation. Tumor volume was quantified by manual segmentation. The influences of EOR, patient age, recurrent tumor, tumor localization, and gender on survival time were examined. Intraoperative MRI detected residual tumor volume in 88 patients. In 19 patients surgery was continued; further resection resulted in final gross total resection (GTR) for 9 patients (GTR increased from 47 [34.80%] to 56 [41.49%] patients). Tumor volumes were significantly reduced from 34.25 ± 23.68% (first iMRI) to 1.22 ± 16.24% (final iMRI). According to Kaplan-Meier estimates, median survival was 14 months (95% confidence interval [CI]: 11.7-16.2) for EOR ≥ 98% and 9 months (95% CI: 7.4-10.5) for EOR <98% (P< .0001); it was 9 months (95% CI: 7.3-10.7) for patients ≥ 65 years and 12 months (95% CI: 8.4-15.6) for patients <65 years (P < .05). Multivariate analysis showed a hazard ratio of 0.39 (95% CI: 0.24-0.63; P = .001) for EOR ≥ 98% and 0.61 (95% CI: 0.38-0.97; P < .05) for patient age <65 years. To our knowledge, this is the largest study including correlation of iMRI, tumor volumetry, and survival time. We demonstrate that navigation guidance and iMRI significantly contribute to optimal EOR with low postoperative morbidity, where EOR ≥ 98% and patient age <65 years are associated with significant survival advantages. Thus, maximum EOR should be the surgical goal in GBM surgery while preserving neurological function.
在多形性胶质母细胞瘤(GBM)的治疗中,最大限度切除肿瘤(EOR)仍然存在争议。然而,越来越多的研究倾向于最大限度地切除肿瘤,因为这与患者生存时间延长有关。135 名 GBM 患者接受了 1.5T 术中磁共振成像(iMRI)和集成多模态导航辅助下的肿瘤切除术。通过手动分割来量化肿瘤体积。检查了 EOR、患者年龄、复发性肿瘤、肿瘤定位和性别对生存时间的影响。术中 MRI 检测到 88 名患者的残余肿瘤体积。在 19 名患者中继续进行手术;进一步切除导致最终大体全切除(GTR)的患者有 9 名(GTR 从 47 [34.80%]增加到 56 [41.49%])。肿瘤体积从 34.25±23.68%(首次 iMRI)显著减少至 1.22±16.24%(最终 iMRI)。根据 Kaplan-Meier 估计,EOR≥98%的中位生存时间为 14 个月(95%CI:11.7-16.2),EOR<98%的中位生存时间为 9 个月(95%CI:7.4-10.5)(P<.0001);年龄≥65 岁的患者中位生存时间为 9 个月(95%CI:7.3-10.7),年龄<65 岁的患者中位生存时间为 12 个月(95%CI:8.4-15.6)(P <.05)。多变量分析显示,EOR≥98%的危险比为 0.39(95%CI:0.24-0.63;P=.001),年龄<65 岁的危险比为 0.61(95%CI:0.38-0.97;P<.05)。据我们所知,这是最大的研究,包括 iMRI、肿瘤体积测量和生存时间的相关性。我们证明导航引导和 iMRI 显著有助于实现最佳 EOR,同时术后发病率低,EOR≥98%和患者年龄<65 岁与显著的生存优势相关。因此,在保留神经功能的情况下,最大限度地切除肿瘤应成为 GBM 手术的目标。
Neurochirurgie. 2014-8
Zhonghua Wai Ke Za Zhi. 2013-6-1
J Neurol Surg A Cent Eur Neurosurg. 2019-11
J Neurooncol. 2025-7-3
Biomed Opt Express. 2024-3-13
Biomedicines. 2023-12-20
IEEE J Transl Eng Health Med. 2024
Clin Neurol Neurosurg. 2010-4
Top Magn Reson Imaging. 2009-1
Neurosurgery. 2008-4
J Clin Oncol. 2008-3-10